Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study

医学 中止 类风湿性关节炎 内科学 不利影响 队列 入射(几何) 胃肠病学 光学 物理
作者
Sadao Jinno,Akira Ōnishi,Shuhei Hattori,Maureen Dubreuil,Yo Ueda,Keisuke Nishimura,T. Okano,H. Yamada,Wataru Yamamoto,Koichi Murata,Hideo Onizawa,Kosuke Ebina,Yuichi Maeda,Yonsu Son,Hideki Amuro,Ryota Hara,Kenichiro Hata,Hideyuki Shiba,Masaki Katayama,Ryu Watanabe,Motomu Hashimoto,Jun Saegusa
出处
期刊:Rheumatology [Oxford University Press]
标识
DOI:10.1093/rheumatology/keae081
摘要

Abstract Objectives This multicentre, retrospective study aimed to compare retention and reasons for discontinuation between Janus kinase inhibitors (JAKi) and biologic DMARDs in patients with elderly-onset rheumatoid arthritis (EORA). Methods Patients with RA enrolled in a Japanese multicentre observational registry between 2015 and 2022 were included. EORA was defined as RA with onset at age 60 or over. To adjust confounding factors by indication for initiation of TNF inhibitors (TNFi), IL-6 inhibitors (IL-6i), cytotoxic T-lymphocyte associated antigen 4 immunoglobulin (CTLA4-Ig) blockers, or JAKi, a propensity score based on baseline characteristics was used to compare drug retention. To assess the reasons for discontinuation, retention rates for ineffectiveness, adverse events and remission were analysed as secondary outcomes. Results A total of 572 patients with 835 treatment courses were identified (314 TNFi, 175 IL-6i, 228 CTLA4-Ig and 118 JAKi). After adjusting for differences in baseline characteristics, drug retention was significantly higher for IL-6i (hazard ratio [HR] = 0.38; 95% CI: 0.27, 0.55; P < 0.01) as compared with TNFi. Discontinuation due to lack of effectiveness was lower with JAKi (HR = 0.38; 95% CI: 0.22, 0.66; P < 0.01) and IL-6i (HR = 0.29; 95% CI: 0.19, 0.46; P < 0.01) as compared with TNFi although CTLA4-Ig had a similar HR to TNFi. The adjusted incidence of discontinuation due to adverse events was higher for JAKi (HR = 2.86; 95% CI: 1.46, 5.59; P < 0.01) than for TNFi. Conclusion In EORA patients, IL-6i and JAKi had longer retention and less discontinuation due to ineffectiveness than TNFi. The potential risks of JAKi should be approached with an individualized perspective.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汉堡包的应助被犹豫的牛排采纳,获得30
刚刚
mw完成签到,获得积分20
刚刚
过时的疾发布了新的文献求助10
1秒前
1秒前
1秒前
852的应助被黑猫黑猫采纳,获得10
1秒前
1秒前
蒸汽秋葵的应助被笑点低愫采纳,获得10
2秒前
英姑的应助被小白狗采纳,获得10
2秒前
tong发布了新的文献求助10
2秒前
玛卡巴卡发布了新的文献求助30
2秒前
2秒前
小猪熊完成签到,获得积分10
4秒前
wchwei123完成签到,获得积分10
4秒前
Box完成签到,获得积分10
5秒前
5秒前
wanci的应助被Joshua采纳,获得10
5秒前
小马猪发布了新的文献求助20
5秒前
5秒前
酷酷雪曼发布了新的文献求助10
5秒前
852的应助被why采纳,获得10
6秒前
充电宝的应助被quester采纳,获得10
6秒前
hannah完成签到,获得积分10
6秒前
丘比特的应助被过时的疾采纳,获得10
6秒前
6秒前
Jasper的应助被baiweizi采纳,获得10
7秒前
多米发布了新的文献求助10
7秒前
7秒前
Jie发布了新的文献求助10
7秒前
7秒前
666完成签到 ,获得积分10
7秒前
Xty007完成签到,获得积分10
8秒前
SciGPT的应助被刘宇翔采纳,获得30
8秒前
8秒前
冷酷的断缘完成签到 ,获得积分10
8秒前
曹牛牛发布了新的文献求助10
8秒前
CipherSage的应助被Box采纳,获得10
8秒前
xiaole完成签到,获得积分10
8秒前
9秒前
李某某发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160467
求助须知:如何正确求助?哪些是违规求助? 9555463
关于积分的说明 21728123
捐赠科研通 7750270
什么是DOI,文献DOI怎么找? 3427393
关于科研通互助平台的介绍 2552425
邀请新用户注册赠送积分活动 2471741